DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, S. C.
Right arrow Articles by Mirvish, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, S. C.
Right arrow Articles by Mirvish, S. S.

Vol. 29, Issue 9, 1221-1228, September 2001

Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3

Sheng Chong Chen,1 Lin Zhou, Xinxin Ding, and Sidney S. Mirvish

Eppley Institute for Research in Cancer (S.C.C., L.Z., S.S.M.) and Departments of Biochemistry and Molecular Biology and of Pharmaceutical Sciences (S.S.M.), University of Nebraska Medical Center, Omaha, Nebraska; and Wadsworth Center, New York State Department of Health and School of Public Health (X.D.), State University of New York, Albany, New York

Methyl-n-pentylnitrosamine (MPN) is carcinogenic for the rat esophagus. To determine organ specificity for MPN activation by human tissues, microsomes isolated from human organs (snap-frozen <6 h after death or removed surgically) were incubated with [pentyl-3H]MPN, and [3H]pentaldehyde formation was measured by high-pressure liquid chromatography of its 2,4-dinitrophenylhydrazone using radioflow assay. With 100 µM MPN, mean depentylation rates were 6.6 (liver), 2.9 to 3.8 (kidney, stomach, small intestine, and colon), and 0.4 to 1.6 (esophagus, lung, and skin) pmol of pentaldehyde/mg of protein/min. Of 14 human esophagi, four showed relatively high depentylation rates of 3.3 to 4.1 pmol/mg/min. Apparent Km was 80 to 160 µM (Vmax, 3-15 pmol/mg/min) for three esophagi, 90 to 130 (2 livers), and 1330 (1 kidney) µM. Rat tissues showed mean depentylation rates for 100 µM MPN of 24.9 (liver), 14.5 (esophagus), 7.0 (lung), and 0.0 to 2.7 (5 other tissues) pmol/mg/min. MPN depentylation by rat cytochrome P450 2A3 showed an apparent Km of 8 µM (Vmax, 70 pmol/nmol of P450/min) and was competitively inhibited by the CYP2A inhibitor coumarin (apparent Ki, 4 µM). Coumarin (0.4 mM) inhibited microsomal depentylation of 100 µM MPN by 37 to 62% for human esophagus, liver, kidney, and colon and for rat esophagus but not for rat liver and lung. MPN depentylation by rat esophageal microsomes increased up to 90% on adding P450 reductase. The results indicate organ-specific MPN metabolism by rat but not human esophagus. Nevertheless, the relatively high activity of four human esophagi might indicate increased susceptibility of some individuals to carcinogenesis by unsymmetrical dialkylnitrosamines.


1 Parts of this study were presented at two meetings (Chen and Mirvish, 1996; Chen et al., 1999b).


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
GutHome page
H Suzuki, K Iijima, A Moriya, K McElroy, G Scobie, V Fyfe, and K E L McColl
Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia
Gut, August 1, 2003; 52(8): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. L. Wong, S. E. Murphy, M. Wang, and S. S. Hecht
Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3
Carcinogenesis, February 1, 2003; 24(2): 291 - 300.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.